Abbott (NYSE: ABT) reported third quarter 2022 earnings results today. Sales decreased 4.7% year-over-year to $10.4 billion. On an organic basis, sales increased 1.3%. Net earnings declined 31.7% to $1.4 billion while EPS fell 30.8% to $0.81. Adjusted EPS dropped 18% to $1.15. For FY2022, Abbott expects adjusted EPS to be $5.17-5.23. Prior performance
Abbott (NYSE: ABT) reported third quarter 2022 earnings results today. Sales decreased 4.7% year-over-year to $10.4 billion. On an organic basis, sales increased 1.3%. Net earnings declined 31.7% to $1.4 billion while EPS fell 30.8% to $0.81. Adjusted EPS dropped 18% to $1.15. For FY2022, Abbott expects adjusted EPS to be $5.17-5.23. Prior performance
Abbott (NYSE: ABT) reported third quarter 2022 earnings results today.
Sales decreased 4.7% year-over-year to $10.4 billion. On an organic basis, sales increased 1.3%.
Net earnings declined 31.7% to $1.4 billion while EPS fell 30.8% to $0.81. Adjusted EPS dropped 18% to $1.15.
For FY2022, Abbott expects adjusted EPS to be $5.17-5.23.
